H
Haptena Therapeutics
Raised $3.5M in a Seed round, announced 16 December 2025.
- Total raised
- $3.5M
Latest round SeedCountry 🇮🇹ItalySector Health
Round
$3.5MSeed, 16 December 2025
Seed fully subscribed by Claris Ventures to take its KRAS G12C program to preclinical validation in lung cancer.
- Amount
- $3.5M
- Stage
- Seed
- Announced
- 16 December 2025
- Lead
- Claris Ventures
- Use of funds
- Seed fully subscribed by Claris Ventures to take its KRAS G12C program to preclinical validation in lung cancer.
- Checked
- Amount and date checked against the press source
- Source
- Haptena Therapeutics raises 3M euro seed from Claris Ventures startupbusiness.it
Company
Develops therapies against KRAS-mutated and other oncogene-driven cancers
- Based in
- Turin, 🇮🇹Italy
- Sector
- Health
- Website
- haptena.com ↗
Questions
How much has Haptena Therapeutics raised?
Haptena Therapeutics raised $3.5M in a Seed round, announced on 16 December 2025.
Who invested in Haptena Therapeutics?
Claris Ventures led. Investors include Claris Ventures.
